Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated:  6/8/2016
West Tennessee Research Institute
mi
from
Jackson, TN
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated: 6/8/2016
West Tennessee Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated:  6/8/2016
Rheumatology Consultants Pllc
mi
from
Knoxville, TN
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated: 6/8/2016
Rheumatology Consultants Pllc
mi
from
Knoxville, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated:  6/8/2016
Seattle Rheumatology Associates
mi
from
Seattle, WA
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated: 6/8/2016
Seattle Rheumatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated:  6/8/2016
Arthritis Northwest
mi
from
Spokane, WA
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated: 6/8/2016
Arthritis Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated:  6/8/2016
Local Institution
mi
from
Ciudad Autonoma Beunos Aires,
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis
Status: Enrolling
Updated: 6/8/2016
Local Institution
mi
from
Ciudad Autonoma Beunos Aires,
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Peoria, AZ
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Little Rock, AR
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Cypress, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Hemet, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Hemet, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
La Jolla, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Palo Alto, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Victorville, CA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Victorville, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Sarasota, FL
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
St Petersburg, FL
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Tampa, FL
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Tampa, FL
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Chicago, IL
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Paducah, KY
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Wheaton, MD
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Wheaton, MD
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Boston, MA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Battle Creek, MI
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Lansing, MI
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
St. Louis, MO
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Rochester, NY
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Tulsa, OK
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Waco, TX
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
Clinical Research Facility
mi
from
Seattle, WA
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated:  6/8/2016
mi
from
Calgary,
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
Status: Enrolling
Updated: 6/8/2016
mi
from
Calgary,
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Alliance Dermatology & MOHS Center, PC
mi
from
Phoenix, AZ
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Alliance Dermatology & MOHS Center, PC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Bakersfield Dermatology and Skin Cancer Medical Group
mi
from
Bakersfield, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Bakersfield Dermatology and Skin Cancer Medical Group
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Wallace Medical Group
mi
from
Beverly Hills, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Wallace Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Dr. Howard Sofen
mi
from
Los Angeles, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Dr. Howard Sofen
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Southern California Permanente Medical Group
mi
from
Los Angeles, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Southern California Permanente Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Palmtree Clinical Research
mi
from
Rancho Mirage, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Palmtree Clinical Research
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Medical Center for clinical research
mi
from
San Diego, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  6/9/2016
Clinical Science Institute
mi
from
Santa Monica, CA
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 6/9/2016
Clinical Science Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials